Sally Bridget Lawlor - 18 Aug 2025 Form 3 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Sally Bridget Lawlor
Issuer symbol
QNRX
Transactions as of
18 Aug 2025
Net transactions value
$0
Form type
3
Filing time
08 Sep 2025, 16:31:14 UTC
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lawlor Sally Bridget CHIEF FINANCIAL OFFICER C/O QUOIN PHARMACEUTICALS LTD., 42127 PLEASANT FREST COURT, ASHBURN /s/ Sally Bridget Lawlor 08 Sep 2025 0002084407

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QNRX ADS 440 18 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.

Remarks:

Exhibit List - Exhibit 24.1: Power of Attorney